Bill > HR5905

This bill, the Federal Kratom Consumer Protection Act, aims to protect access to kratom, a botanical substance derived from the Mitragyna speciosa plant. The key provisions of the bill include: 1. Requiring the Secretary of Health and Human Services, through the FDA Commissioner, to hold at least one public hearing to discuss the current scientific data and information about the safety and use of kratom and kratom-derived products. 2. Establishing a Kratom Research Task Force to coordinate federally funded kratom-related research and provide regular reports to Congress and the FDA. 3. Prohibiting the FDA from imposing more restrictive requirements on kratom or kratom-derived products than those for food, dietary supplements, and dietary ingredients under the Federal Food, Drug, and Cosmetic Act. 4. Requiring the FDA to comply with formal rulemaking procedures, including public hearings, for any future regulations on kratom. 5. Restricting the FDA's ability to issue import alerts for kratom or kratom-derived products unless there is evidence of adulteration. The bill aims to ensure transparent and evidence-based policymaking around the regulation of kratom, a substance that is used by many individuals in the United States and has potential health and wellness benefits.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/118th-congress/house-bill/5905/all-info